Skip to content

Data Acquisition to Model Glycemic Response

Data Acquisition to Model Glycemic Response to Food and Other Events Using Real-Time Continuous Glucose Monitoring (RT-CGM)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03612999
Acronym
SDI
Enrollment
102
Registered
2018-08-02
Start date
2018-05-31
Completion date
2020-09-23
Last updated
2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

To learn about individual glycemic response to physiological and psychological conditions across a diverse population, the investigators will collect sensor and lifestyle data directly from participants as they engage in daily activities. The investigators will collect real-time glucose data from a continuous glucose monitor (CGM) system; accelerometer, aggregated activity, and sleep data from a wrist-worn activity tracker; mood and experiential data; and food information. Non-sensor data will be collected using a paper log, or via a study app when available.

Interventions

Continuous glucose monitors (CGMs) record subjects glucose levels

Activity trackers will record subjects' physical activity, heart rate, and sleep.

BEHAVIORALSubjects record daily activity

Subjects will record their daily activities, either on paper or on a secure texting app.

BEHAVIORALSubjects record psychological state

Subjects will record their psychological state, either on paper or on a secure texting app.

Sponsors

Savvysherpa, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be at least 18 years old * Be able to read, speak, and understand English * Have a primary care provider

Exclusion criteria

* Not receive or require kidney dialysis * Not be pregnant * Not have type 1 diabetes * Not have type 2 diabetes and be prescribed three or more daily injections of insulin

Design outcomes

Primary

MeasureTime frameDescription
Glucose Level (mg./dl.)20 days per participantEstimated glucose concentration (mg./dl.) sampled every five minutes by a continuous glucose monitor (CGM).

Secondary

MeasureTime frameDescription
Food Consumption (type and quantity)20 days per participantFood items as described by user in food logs, along with time of consumption.
Activities of daily living (free form)20 days per participantParticipants may log any activity of daily living they choose, including social interactions, house work, and leisure activities. Activities are described by users and logged in interval form with start-time and end-times.
Activity level (steps per hour)20 days per participantActivity level (steps per hour) as determined from data from wrist-worn accelerometer
Sensor wear time (wear / no-wear intervals)20 days per participantParticipants will log intervals in which they are and are not wearing the CGM over the course of their participation in the study.
Transmitter life expectancy (number of minutes)20 days per participantIn cases where participants wear sensors until the end of the transmitter's life, the number of minutes transmitter was operational.
Psychological state (free-form)20 days per participantParticipants may log any psychological information they choose including mood, energy level, or cognitive function. Psychological states are described by users and logged with time or interval in which that psychological state was experienced.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026